Across TCGA pan-cancer cohorts, LCN10 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LCN10’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LCN10 RNA is repressed in tumor relative to normal tissue. In most cancer types LCN10 is over-expressed in tumor, although a few such as BLCA and COAD show the opposite, repressed pattern.
BLCA, COAD, and KIRP are the cancer types where LCN10 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LCN10 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.